VCYT Veracyte Corp: Rasio Kapitalisasi Pasar marang Nilai Buku

Veracyte, Inc. (VCYT) leverages advanced AI algorithms and unique RNA signatures to help clinics avoid unnecessary surgical interventions. The business is protected by years of clinical validation and patents, which make it impossible to replicate its medical database. The current metric stands at 2.82. The stock's price chart demonstrates scaling potential through a laboratory network, which significantly reduces the cost per individual analysis.

Veracyte, Inc. (VCYT) - Rasio Kapitalisasi Pasar marang Nilai Buku saka 04.07.2022 nganti 27.10.2026

VCYT (Veracyte Inc): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:

Kutipan saham Veracyte, Inc.|VCYT - Rega prakiraan analis

- data kapitalisasi pasar:

Kapitalisasi pasar Veracyte Corp|VCYT - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Veracyte|VCYT - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku veracyte.com|VCYT - Total Aset Bisnis

- data utang lan likuiditas:

Total Utang marang Modal Veracyte, Inc.|VCYT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Veracyte Corp|VCYT - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Veracyte Corp

Pambiji fundamental:VCYT (Veracyte, Inc.)

The protection of the Veracyte, Inc. (VCYT) genomic platform through patents and insurance coverage is reflected in the price-to-book ratio dynamics. This indicator compares the current market share price with the company's net assets, allowing investors to assess the premium paid for intellectual capital and determine the fair value of the business relative to average US market industry thresholds.

Pesaing utama